UPDATE 1-Roche sees profit growth won't outstrip sales in 2017
ZURICH, Feb 1 (Reuters) - Roche on Wednesday forecast profit growth would not outstrip sales in 2017, with the biggest maker of cancer drugs facing competition for its older blockbuster medicines for the first time as patents expire. [Source]
Publication Date:Origin: reuters.com
Category: rbssHealthcareNews
Topics: sales, outstrip, growth, profit, patents expire, first, medicines, blockbuster, its older, competition, facing, drugs, cancer, maker, biggest, with the, would, Wednesday forecast, Roche, (Reuters), ZURICH, won't, 1-Roche, UPDATE
Source: http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/hzxhp_waK6I/roche-results-idUSL5N1FM0TN